Volume 30, Issue 3 (September 2026)
Physiol Pharmacol 2026, 30(3): 329-339 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mehrab Mohseni M, Bararian K, Banan Z, Naseroleslami M, Aboutaleb N. Protective effects of simvastatin-loaded nano-niosomes against myocardial ischemia/reperfusion-induced acute kidney injury. Physiol Pharmacol 2026; 30 (3) :329-339
URL: http://ppj.phypha.ir/article-1-2622-en.html
URL: http://ppj.phypha.ir/article-1-2622-en.html
Abstract: (390 Views)
Introduction: Although simvastatin attenuates renal injury in several ways, its poor solubility and bioavailability may reduce its efficiency. This study evaluated the effect of simvastatin-loaded nano-niosomes against myocardial ischemia/reperfusion (MI/R)-induced kidney failure and compared its efficiency with simvastatin.
Methods: Nano-niosomes were prepared using the surface-active agent film hydration method. For inducing MI/R, the left anterior descending artery (LAD) was ligated, and then recirculation was established. Drug formulations at a concentration of 3 mg/kg were administered into the myocardial tissue. Western blot assay was applied to measure protein levels. An ELISA assay was used to evaluate the expression of inflammatory cytokines, oxidative stress markers, and markers of renal function. H&E staining was done to determine tissue damage.
Results: The induction of MI/R in rats increased serum levels of creatinine, BUN, and uric acid; elevated levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-11), NF-κB, BAX, and caspase-3 in renal tissue; and decreased the activities of antioxidant enzymes SOD, GPX, and catalase, as well as Bcl-2 protein in renal tissue. Although all of these changes were neutralized by medication with simvastatin and simvastatin-loaded nano-niosomes, simvastatin-loaded nano-niosomes had a more powerful impact on reducing MI/R-induced renal injury compared to simvastatin.
Conclusion: The outcomes conclude that nano-niosomes can be considered a good candidate to improve the efficiency of simvastatin against MI/R-induced renal injury. Simvastatin-loaded nano-niosomes are capable of reducing MI/R-induced renal injury and improving renal function by reducing inflammation, suppressing oxidative stress, targeting NF-κB protein, and attenuating apoptotic cell death.
Type of Manuscript: Experimental research article |
Subject:
Renal Physiology/Pharmacology
References
1. Anavekar N S, McMurray J J, Velazquez E J, Solomon S D, Kober L, Rouleau J-L, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. New England Journal of Medicine 2004; 351: 1285-1295. [DOI:10.1056/NEJMoa041365]
2. Bahrololoumi S, Nikazar S. Niosomes as a promising nanovesicular drug delivery. Advanced and Modern Approaches for Drug Delivery: Elsevier, 2023: 223-258. [DOI:10.1016/B978-0-323-91668-4.00011-3]
3. Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. British Medical Journal 2010; 341: c3365. [DOI:10.1136/bmj.c3365]
4. Chade A R, Zhu X, Mushin O P, Napoli C, Lerman A, Lerman L O. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB Journal 2006; 20: 1706-1708. [DOI:10.1096/fj.05-5680fje]
5. Chen T-H, Liao F-T, Yang Y-C, Wang J-J. Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury− induced acute renal injury. Transplantation Proceedings 2014; 46: 1123-1126. [DOI:10.1016/j.transproceed.2013.12.018]
6. Choi Y S, Shim J K, Kim J C, Kang K S, Seo Y H, Ahn K R, et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. J Journal of Thoracic and Cardiovascular Surgery 2011; 142: 148-154. [DOI:10.1016/j.jtcvs.2010.11.018]
7. Englberger L, Suri R M, Greason K L, Burkhart H M, Sundt III T M, Daly R C, et al. Deep hypothermic circulatory arrest is not a risk factor for acute kidney injury in thoracic aortic surgery. The Journal of Thoracic And Cardiovascular Surgery 2011; 141: 552-558. [DOI:10.1016/j.jtcvs.2010.02.045]
8. Ernandez T, Mayadas T N. The Changing Landscape of Renal Inflammation. Trends in Molecular Medicine 2016; 22: 151-163. [DOI:10.1016/j.molmed.2015.12.002]
9. Fu E L, Franko M A, Obergfell A, Dekker F W, Gabrielsen A, Jernberg T, et al. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients. American Heart Journal 2019; 216: 20-29. [DOI:10.1016/j.ahj.2019.06.019]
10. Fujii H, Yonekura Y, Yamashita Y, Kono K, Nakai K, Goto S, et al. Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction. British Journal of Pharmacology 2016; 173: 1302-1313. [DOI:10.1111/bph.13417]
11. Gallagher S M, Jones D A, Kapur A, Wragg A, Harwood S M, Mathur R, et al. Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery. Kidney International 2015; 87: 473-481. [DOI:10.1038/ki.2014.259]
12. Grayson A D, Khater M, Jackson M, Fox M A. Valvular heart operation is an independent risk factor for acute renal failure. The Annals of Thoracic Surgery 2003; 75: 1829-1835. [DOI:10.1016/S0003-4975(03)00166-8]
13. Henke N, Schmidt-Ullrich R, Dechend R, Park J K, Qadri F, Wellner M, et al. Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circulation Research 2007; 101: 268-276. [DOI:10.1161/CIRCRESAHA.107.150474]
14. Ighodaro O, Akinloye O. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria Journal of Medicine 2018; 54: 287-293. [DOI:10.1016/j.ajme.2017.09.001]
15. Izhar M P, Hafeez A, Kushwaha P, Simrah. Drug delivery through niosomes: A comprehensive review with therapeutic applications. Journal of Cluster Science 2023; 34: 2257-2273. [DOI:10.1007/s10876-023-02423-w]
16. Kafkasli A, Ozkorkmaz E G. Prolonged simvastatin treatment provided a decrease in apoptotic, inflammatory, and oxidative stress markers in ischemia-reperfusion-induced acute kidney injury model of rats. Analytical and Quantitative Cytopathology and Histopathology 2021; 43: 167-173.
17. Lee J H, Islam M S, Yoo Y J, Kim S E, Kim R H, Jang Y J, et al. Changes of antioxidant enzymes in the kidney after cardiac arrest in the rat model. Brazilian Journal of Medical and Biological Research 2023; 56: e12408. [DOI:10.1590/1414-431x2023e12408]
18. Li X, Zou Y, Fu Y-Y, Xing J, Wang K-Y, Wan P-Z, et al. Ibudilast attenuates folic acid-induced acute kidney injury by blocking pyroptosis through TLR4-mediated NF-κB and MAPK signaling pathways. Frontiers in Pharmacology 2021; 12: 650283. [DOI:10.3389/fphar.2021.650283]
19. Naseroleslami M, Niri N M, Akbarzade I, Sharifi M, Aboutaleb N. Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury. Drug Delivery and Translational Research 2022; 12: 1423-1432. [DOI:10.1007/s13346-021-01019-z]
20. Nežić L, Škrbić R, Amidžić L, Gajanin R, Milovanović Z, Nepovimova E, et al. Protective effects of simvastatin on endotoxin-induced acute kidney injury through activation of tubular epithelial cells’ survival and hindering cytochrome C-mediated apoptosis. International Journal of Molecular Sciences 2020; 21: 7236. [DOI:10.3390/ijms21197236]
21. Ozer M K, Parlakpinar H, Vardi N, Cigremis Y, Ucar M, Acet A. Myocardial ischemia/reperfusion-induced oxidative renal damage in rats: protection by caffeic acid phenethyl ester (CAPE). Shock 2005; 24: 97-100. [DOI:10.1097/01.shk.0000168525.97716.28]
22. Pang J, Chan D C, Watts G F. The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia. Current Atherosclerosis Reports 2020; 22: 64. [DOI:10.1007/s11883-020-00884-2]
23. Pickering J W, James M T, Palmer S C. Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. American Journal of Kidney Diseases 2015; 65: 283-293. [DOI:10.1053/j.ajkd.2014.09.008]
24. Piko N, Bevc S, Hojs R, Ekart R. The role of oxidative stress in kidney injury. Antioxidants (Basel) 2023; 12: 1772. [DOI:10.3390/antiox12091772]
25. Rangaswami J, Bhalla V, Blair J E A, Chang T I, Costa S, Lentine K L, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the american heart association. Circulation 2019; 139: e840-e878. [DOI:10.1161/CIR.0000000000000664]
26. Ruparelia N, Digby J E, Jefferson A, Medway D J, Neubauer S, Lygate C A, et al. Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflammation Research 2013; 62: 515-525. [DOI:10.1007/s00011-013-0605-4]
27. Tang C, Hu Y, Gao J, Jiang J, Shi S, Wang J, et al. Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sciences 2020; 257: 118004. [DOI:10.1016/j.lfs.2020.118004]
28. Tian Y, Chen Y, Deng B, Liu G, Ji Z-G, Zhao Q-Z, et al. Serum uric acid as an index of impaired renal function in congestive heart failure. Journal of geriatric cardiology 2012; 9: 137. [DOI:10.3724/SP.J.1263.2011.11281]
29. Tokgozoglu L, Zamorano J L. Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin. Drugs Context 2020; 9. [DOI:10.7573/dic.2020-4-4]
30. Tong X, Zhao H, Lu X. Renal damage induced by myocardial ischemia reperfusion in mouse: Role of oxidative stress. Indian Journal of Animal Research 2020; 54: 1486-1489. [DOI:10.18805/ijar.B-1150]
31. Ullah F, Ali Khan M F, Khan N H, Rehman M F, Shah S S, Mustaqeem M, et al. Simvastatin-loaded lipid emulsion nanoparticles: characterizations and applications. ACS Omega 2022; 7: 23643-23652. [DOI:10.1021/acsomega.2c02242]
32. Wen Z, Mai Z, Zhu X, Chen Y, Geng D, Wang J. Comparison of renal impairment post-myocardial infarction with reduced and preserved left ventricular function in rats with normal renal function. Renal Failure 2020; 42: 358-368. [DOI:10.1080/0886022X.2020.1752241]
33. Werner R A, Hess A, Koenig T, Diekmann J, Derlin T, Melk A, et al. Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarction. Theranostics 2021; 11: 7984-7994. [DOI:10.7150/thno.61423]
34. Zhang H, Sun S C. NF-kappaB in inflammation and renal diseases. Cell & Bioscience 2015; 5: 63. [DOI:10.1186/s13578-015-0056-4]
35. Zhang Y, Rong S, Feng Y, Zhao L, Hong J, Wang R, et al. Simvastatin attenuates renal ischemia/reperfusion injury from oxidative stress via targeting Nrf2/HO-1 pathway. Experimental and Therapeutic Medicine 2017; 14: 4460-4466. [DOI:10.3892/etm.2017.5023]
36. Zhang Y, Tang P M, Niu Y, Garcia Cordoba C A, Huang X R, Yu C, et al. Long Non-coding RNA LRNA9884 Promotes Acute Kidney Injury via Regulating NF-kB-Mediated Transcriptional Activation of MIF. Frontiers in Physiology 2020; 11: 590027. [DOI:10.3389/fphys.2020.590027]
37. Zhao Y, Feng Q, Huang Z, Li W, Chen B, Jiang L, et al. Simvastatin inhibits inflammation in ischemia-reperfusion injury. Inflammation 2014; 37: 1865-75. [DOI:10.1007/s10753-014-9918-x]
38. Zhou L, Tang S, Li F, Wu Y, Li S, Cui L, et al. Ceria nanoparticles prophylactic used for renal ischemia-reperfusion injury treatment by attenuating oxidative stress and inflammatory response. Biomaterials 2022; 287: 121686. [DOI:10.1016/j.biomaterials.2022.121686]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
